Roche Holding AG

RHO

Company Profile

  • Business description

    Roche is a Swiss biopharmaceutical and diagnostic company. The firm's bestselling pharmaceutical products include a variety of oncology therapies from acquired partner Genentech, and its diagnostics group was bolstered by the acquisition of Ventana in 2008. Oncology products account for 50% of pharmaceutical sales, and centralized and point-of-care diagnostics for more than half of diagnostic-related sales.

  • Contact

    Grenzacherstrasse 124
    Basel4070
    CHE

    T: +41 616881111

    E: [email protected]

    https://www.roche.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - General

    Fiscal Year End

    31 December 2026

    Employees

    112,774

Roche Holding AG News & Analysis

markets

Asian markets are globalising

In an era of onshoring and localisation, revenue sources show an increasingly interconnected world economy

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,708.90131.60-1.49%
CAC 407,993.4952.31-0.65%
DAX 4023,591.03224.72-0.94%
Dow JONES (US)47,501.55453.19-0.95%
FTSE 10010,284.75129.19-1.24%
HKSE25,028.52728.77-2.83%
NASDAQ22,387.68361.31-1.59%
Nikkei 22551,624.233,996.61-7.19%
NZX 50 Index13,099.55518.34-3.81%
S&P 5006,740.0290.69-1.33%
S&P/ASX 2008,483.90118.40-1.38%
SSE Composite Index4,071.1953.00-1.29%

Market Movers